AQST - Aquestive Therapeutics' (AQST) CEO Keith Kendall on Q2 2021 Results - Earnings Call Transcript

Aquestive Therapeutics, Inc. (AQST) Q2 2021 Earnings Conference Call August 4, 2021, 8:00 am ET Company Participants Stephanie Carrington - IR Keith Kendall - President & CEO Ernie Toth - CFO Ken Marshall - SVP, CCO Dan Barber - COO Conference Call Participants Evan Seigerman - BMO Capital Markets Jason Butler - JMP Securities Daniel Busby - RBC Capital Markets Thomas Flaten - Lake Street Capital Andreas Argyrides - Wedbush Ram Selvaraju - H.C. Wainwright Presentation Operator Good day and thank you for standing by. Welcome to the Second Quarter 2021 Aquestive Therapeutics Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions]. Please be advised that today's conference may be recorded. I would now like to hand the conference over to your speaker today, Stephanie Carrington with Investor Relations. Please go ahead. Stephanie Carrington

For further details see:

Aquestive Therapeutics' (AQST) CEO Keith Kendall on Q2 2021 Results - Earnings Call Transcript